MIAMI, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology ...

PHAT is a facial rejuvenation therapy that combines nanofat and its stem cells with PRP for anti-aging that lasts for more ...

Instead of sending tourists to space, scientists have found a more practical use for the final frontier: growing better ...

For the quarter ended September 30, 2024, the Company had a loss from operations of $2.3 million, a 26% year-over-year improvement from $3.1 million for the comparable period of 2023, and a 9% ...

cell therapy, disease diagnostics, circulating tumor cells, regenerative medicine, and vaccine delivery. Researchers can now achieve downstream analysis of materials that were previously unable to be ...

bone tissue regeneration, neuroprotection, immune system modulation, and antimicrobial therapy. * tFNAs' multiple applications from structure-based regulation of cell biology to drug carriers. For ...

Lumixa ®, which acts through photobiomodulation light stimuli activating biological processes and regeneration mechanisms of the skin ... at 13:05 Mevion Delivers Wisconsin's First Compact Proton ...

“Exercise increases blood circulation, which helps deliver oxygen and essential nutrients to the skin to promote cell regeneration and repair ... published in Signal Transduction and Targeted Therapy, ...

The global ageing population and growing awareness of the benefits of orthobiologic therapy are driving the size of the global orthobiologics market.

A research team has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve treatment outcomes for patients with small cell bladder cancer and small cell ...

MIT engineers find that exercise-induced myokines significantly boost neuron growth, offering insights for nerve injury ...